Traub Capital Management LLC Astrazeneca PLC Transaction History
Traub Capital Management LLC
- $101 Billion
- Q3 2025
A detailed history of Traub Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Traub Capital Management LLC holds 4,115 shares of AZN stock, worth $367,881. This represents 0.31% of its overall portfolio holdings.
Number of Shares
4,115
Previous 3,985
3.26%
Holding current value
$367,881
Previous $278 Million
13.37%
% of portfolio
0.31%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...